Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.
暂无分享,去创建一个
[1] M. Cazzola,et al. The use of bronchodilators in stable chronic obstructive pulmonary disease. , 1997, Pulmonary pharmacology & therapeutics.
[2] S. Rennard. Extended bronchodilator treatment in chronic obstructive pulmonary disease , 1996 .
[3] W. Ulmer,et al. [Responder and non-responder in the bronchodilator test?]. , 1995, Pneumologie.
[4] J C Yernault,et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.
[5] P. Calverley. Symptomatic Bronchodilator Treatment , 1995 .
[6] M. Cazzola,et al. Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease. , 1994, Pulmonary pharmacology.
[7] G. Guyatt,et al. Acute Response to Bronchodilator: An Imperfect Guide for Bronchodilator Therapy in Chronic Airflow Limitation , 1988 .
[8] Buist As. Standardization of spirometry. , 1987 .
[9] G. Mchardy,et al. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. , 1987, Thorax.
[10] J. Marini,et al. The effect of atropine inhalation in "irreversible" chronic bronchitis. , 1980, Chest.